Role of Interleukin (IL)-18 in experimental paracoccidioidomycosis

Medical Mycology

Volumn 46, Issue 5, 2008, Pages 435-442

  Panagio, Luciano A ^a   Tristao, Fabrine S M ^a   Moreira, Ana P ^a   Pereira, Marcelo S F ^a   Cavassani, Karen A ^a   Milanezi, Cristiane M ^a   Rossi, Marcos A ^a   Silva, João S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Granulomas; Interleukin 18; Paracoccidioidomycosis

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 18; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIOID CELL; FUNGAL VIRULENCE; FUNGUS ISOLATION; HISTOPATHOLOGY; LUNG GRANULOMA; LUNG LESION; MALE; MORTALITY; MOUSE; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PROTEIN FUNCTION; SOUTH AMERICAN BLASTOMYCOSIS;

ANIMALS; CYTOKINES; GRANULOMA; INTERFERON TYPE II; INTERLEUKIN-18; LUNG; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PARACOCCIDIOIDES; PARACOCCIDIOIDOMYCOSIS; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

MUS; PARACOCCIDIOIDES BRASILIENSIS;

EID: 48249150329     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780801895444     Document Type: Article

References (32)

1. Restrepo, A., McEwen, JG and Castaneda, E. (2001) The habitat of Paracoccidioides brasiliensis: How far from solving the riddle?. 39, pp. 233-241.
2. Souto, JT, Figueiredo, F. Furlanetto, A. et al. (2000) Interferon-γ and Tumor necrosis factor-α determine resistance to Paracoccidioides brasiliensis infection in mice. 156, pp. 1811-1820.
3. Cano, LE, Kashino, SS Arruda, C. et al. (1998) Protective role of gamma interferon in experimental pulmonary paracoccidioidomycosis. 66, pp. 800-806.
4. Dinarello, CA and Fantuzzi, G. (2003) Interleukin-18 and host defense against infection. 187, p. S370.
5. Fantuzzi, G., Reed, DA and Dinarello, CA. (1999) IL-12-induced INF-(is dependent on caspase-1 processing of the IL-18 precursor. 104, pp. 761-767.
6. Castaneda, E., BrummerR, E., Pappagianis, D. and Stevens, DA. (1988) Impairment of cellular but not humoral immune responses in chronic pulmonary and disseminated paracoccidioidomycosis in mice. 56, pp. 1771-1777.
7. Chequer-bou-habib, D., Ribeiro, CD, Banic, DM, do Valle, ACF and Castro, BG. (1989) Polyclonal B cell activation in paracoccidioidomycosis. 108, pp. 89-93.
8. Zhang, T., Kawakami, K. Qureshi, MH et al. (1997) Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. 65, pp. 3594-3599.
9. Qureshi, MH, Zhang, T. Koguchi, Y. et al. (1999) Combined effects of IL-12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans. 29, pp. 643-649.
10. Netea, MG, Vonk, AG van den Hoven, M et al. (2003) Differential role of IL-18 and IL-12 in the host defense against disseminated Candida albicans infection. 33, pp. 3409-3417.
11. Corvino, CL, Mamoni, RL, Fagundez, GZZ and Blotta, M. (2007) Serum interleukin-18 and soluble tumour necrosis factor receptor 2 are associated with disease severity in patients with paracoccidioidomycosis. 147, pp. 483-490.
12. Kawakami, K., Qureshi, MH Zhang, T. et al. (1997) IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-γ production. 159, pp. 5528-5534.
13. Lauw, FN, Branger, J. Florquin, S. et al. (2002) IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. 168, pp. 372-378.
14. Blease, K., Kunkel, SL and Hogaboam, CM. (2001) IL-18 modulates chronic fungal asthma in a murine model; putative involvement of Toll-like receptor-2. 50, pp. 552-560.
15. Nakanishi, K., Yoshimoto, T., Tsutsui, H. and Okamura, H. (2001) Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. 12, pp. 53-72.
16. Helmby, H. and Grencis, RK. (2002) IL-18 regulates intestinal mastocytosis and Th2 cytokine production independently of IFN-γ during Trichinella spiralis infection. 169, pp. 2553-2560.
17. Sasaki, Y., Yoshimoto, T. Maruyama, H. et al. (2005) IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity. 202, pp. 607-616.
18. Nakamura, LT, Wu-Hsieh, BA and Howard, DH. (1994) Recombinant murine gamma interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum. 62, pp. 680-684.
19. Silva, JS, Vespa, GN, Cardoso, MA, Aliberti, JC and Cunha, FQ. (1995) Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon activated macrophages. 63, pp. 4862-4867.
20. Nascimento, FRF, Calich, VLG, Rodriguez, D. and Russo, M. (2002) Dual role for nitric oxide in paracoccidioidomycosis: Essential for resistance, but overproduction associated with susceptibility. 168, pp. 4593-4600.
21. Murphy, JW, Wu-Hsieh, BA Singer-Vermes, LM et al. (1994) Cytokines in the host response to mycotic agents. 32, pp. 203-210.
22. Hunter, CA, Chizzonite, R. and Remington (1995) IL-1 beta is required for IL-12 to induce de production of IFN-gamma by NK cells. 155, pp. 4347-4354.
23. Robinson, D., Shibuya, K. Mui, A. et al. (1997) Igif does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. 7, pp. 571-581.
24. Arruda, C., Franco, MF Kashino, SS et al. (2002) Interleukin-12 protects mice against disseminated infection caused by Paracoccidioides brasiliensis but enhances pulmonary inflammation. 103, pp. 185-195.
25. Stuyt, RJ, Netea, MG, van Krieken, JH, van der Meer, JW and Kullberg, BJ. (2004) Recombinant Interleukin-18 protects against disseminated Candida albicans infection in mice. 189, pp. 1524-1527.
26. Liew, FY. (1993) The role of nitric oxide in parasitic diseases. 87, pp. 637-642.
27. Bocca, AL, Hayashi, EE Pinheiro, AG et al. (1998) Treatment of Paracoccidioides brasiliensis-infected mice with a nitric oxide inhibitor prevents the failure of cell-mediated immune response. 161, pp. 3056-3063.
28. Sugawara, I., Yamada, H. Kaneko, H. et al. (1999) Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. 67, pp. 2585-2589.
29. Akdis, CA and Blaser, K. (2001) Mechanisms of IL-10 mediated immune suppression. 103, pp. 131-136.
30. Romano, CC, Mendes-Giannini, MJS and Duarte, AJS. (2002) IL-12 and neutralization of endogenous IL-10 revert the in vitro antigen-specific cellular immunosuppression of paracoccidiodomycosis patients. 18, pp. 149-157.
31. Wei, XQ, Niedbala, W. Xu, D. et al. (2004) Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection. 94, pp. 35-37.
32. Paterson, GK, Blue, CE and Mitchell, TJ. (2005) Role of interleukin-18 in experimental infections with Streptococcus pneumoniae. 54, pp. 323-326.